Skip to content

WREX Outcome Study

WREX Outcome Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02218593
Enrollment
25
Registered
2014-08-18
Start date
2014-07-31
Completion date
2015-07-31
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthrogryposis, Muscular Dystrophy, Spinal Muscular Atrophy

Brief summary

This study is to evaluate how the Wilmington Robotic Exoskeleton (WREX) is working for children who are using the WREX, or have used it in the past. The survey consists of a set of questions a) performed online and b) performed over the phone.

Detailed description

The WREX (Wilmington Robotic EXoskeleton) is being used by many children with neuromuscular conditions such as arthrogryposis and muscular dystrophy. Nemours/A.I. duPont Hospital for Children alone has provided a WREX for about 80 children in the last 3 years. This is being done through the orthopedic and muscle clinics in the hospital. We would like to perform a retrospective study to see how well the children are doing with the WREX. We propose getting this feedback through a survey administered to families using the WREX. The survey will be performed in two parts. 1) A phone survey will use the Canadian Occupational Performance Measure (COPM). 2) an online survey with additional questions. The parents are asked to submit answers on behalf of the children if they are unable to.

Interventions

DEVICEWREX orthosis

Upper extremity exoskleton used to assist movement

Sponsors

Nemours Children's Clinic
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Neuromuscular disease * Use the Wilmington Robotic Exoskeleton

Exclusion criteria

* people who do not use the Wilmington Robotic Exoskeleton

Design outcomes

Primary

MeasureTime frameDescription
Canadian Occupational Performance Measure (COPM)Surveys were conducted at a single timepoint for each subject. The surveys were administered over a 4-month period for all the subjects.Performance score on The Canadian Occupational Performance Measure (COPM). The total score range is 1-10. A score of 1 indicates indicates poor performance and low satisfaction and 10 indicates good performance and high satisfaction. The numbers indicate scores on a scale.

Participant flow

Participants by arm

ArmCount
WREX Orthosis
Children who have used a WREX Orthosis WREX orthosis: Upper extremity exoskeleton used to assist arm movement
25
Total25

Baseline characteristics

CharacteristicWREX Orthosis
Age, Continuous8.72 years
STANDARD_DEVIATION 1.38
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
25 Participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 25
other
Total, other adverse events
0 / 25
serious
Total, serious adverse events
0 / 25

Outcome results

Primary

Canadian Occupational Performance Measure (COPM)

Performance score on The Canadian Occupational Performance Measure (COPM). The total score range is 1-10. A score of 1 indicates indicates poor performance and low satisfaction and 10 indicates good performance and high satisfaction. The numbers indicate scores on a scale.

Time frame: Surveys were conducted at a single timepoint for each subject. The surveys were administered over a 4-month period for all the subjects.

ArmMeasureValue (MEAN)Dispersion
WREX OrthosisCanadian Occupational Performance Measure (COPM)7.09 score on a scaleStandard Deviation 2.15

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026